Angiogenesis-Related Proteins - Their Role in the Pathogenesis and Treatment of Inflammatory Bowel Disease

Author(s): Piotr Eder, Katarzyna Korybalska, Krzysztof Linke, Janusz Witowski

Journal Name: Current Protein & Peptide Science

Volume 16 , Issue 3 , 2015

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


The etiology of inflammatory bowel disease (IBD) is still not fully understood. Angiogenesis is one of the crucial phenomena sustaining chronic inflammation in the gastrointestinal tract. It has been also shown that the most potent anti-inflammatory drugs - anti-tumor necrosis factor alpha antibodies down-regulate intestinal angiogenesis, what is believed to contribute to their therapeutic efficacy. There are many proteins engaged in gastrointestinal angiogenesis, including pro-inflammatory cytokines, vascular growth factors, and adhesion molecules. Several of them are considered to be promising molecular targets for new drugs - monoclonal antibodies or fusion proteins. Here, we review new data highlighting the key role of proteins that regulate immune-mediated angiogenesis in IBD, like vascular endothelial growth factor, hypoxia inducible factor, angiopoietins, or basic fibroblast growth factor. We present the molecular mechanisms regulating the pathological proangiogenic activity in inflammatory conditions in IBD. We also discuss how new anti-cytokine regimens affect the function of angiogenesis-related proteins.

Keywords: Adhesion molecules, angiogenesis, angiopoietins, hypoxia inducible factor, inflammatory bowel disease, vascular endothelial growth factor, vedolizumab.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 13 March, 2015
Page: [249 - 258]
Pages: 10
DOI: 10.2174/1389203716666150224150756
Price: $65

Article Metrics

PDF: 40